DEBASISH TRIPATHY to Postmenopause
This is a "connection" page, showing publications DEBASISH TRIPATHY has written about Postmenopause.
Connection Strength
0.215
-
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance). J Clin Oncol. 2016 08 01; 34(22):2602-9.
Score: 0.118
-
Aromatase inhibitors: rationale and use in breast cancer. Annu Rev Med. 2005; 56:103-16.
Score: 0.054
-
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021 12 16; 385(25):2336-2347.
Score: 0.043